Evaluation of the benefit and use of the new terminology in endometrial cytology reporting system
ConclusionsThese data suggest that patients with ATEC‐US results can be followed up for at least three months, and the introduction of the NTEMC system decreased the number of unnecessary endometrial biopsies. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 20, 2018 Category: Pathology Authors: Akiko Shinagawa, Tetsuji Kurokawa, Makoto Yamamoto, Toshimichi Onuma, Hideaki Tsuyoshi, Yoko Chino, Kazumi Iwasaki, Masaki Mori, Yoshiaki Imamura, Yoshida Yoshio Tags: ORIGINAL ARTICLE Source Type: research
Immediate biopsy of cervical cytology ‐negative and non‐HPV‐16/18 oncogenic types positive patients
Diagnostic Cytopathology,Volume 46, Issue 4, Page 326-330, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 19, 2018 Category: Pathology Source Type: research
Evaluation of the benefit and use of the new terminology in endometrial cytology reporting system
Diagnostic Cytopathology,Volume 46, Issue 4, Page 314-319, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 19, 2018 Category: Pathology Source Type: research
---
Diagnostic Cytopathology,Volume 46, Issue 4, Page 326-330, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 19, 2018 Category: Pathology Source Type: research
---
Diagnostic Cytopathology,Volume 46, Issue 4, Page 314-319, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 19, 2018 Category: Pathology Source Type: research
Immediate biopsy of cervical cytology ‐negative and non‐HPV‐16/18 oncogenic types positive patients
ConclusionFor the patients who had cervical cytology negative/non‐HPV‐16/18 positive, we detected that 1.1% of these women had CIN 2‐3. For this reason, by chasing the algorithm recommended by guidelines, gynecologists take risk missing a diagnosis of CIN 2 plus lesion in 1.1% of patients. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 19, 2018 Category: Pathology Authors: İbrahim Karaca, Mustafa Öztürk, Cihan Comba, Gökhan Demirayak, İsmail Alay, Volkan Şakir Erdoğan, Murat Hoşgören, Levent Yaşar Tags: ORIGINAL ARTICLE Source Type: research
Molecular diagnostic techniques in cytopathology: From the bench to the patient's bedside
Molecular techniques are increasingly used in everyday practice for patient diagnosis and also to guide therapy. Their application in cytological specimens can allow a more cost‐effective management with fewer risks. However, standardized protocols are needed to guarantee accurate and reproducible results. We herein report five practical examples of the application of ancillary techniques in cytopathology and review the literature on the issue, highlighting the practical aspects of sample management. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Authors: Cristina D íaz del Arco, Mª Jesús Fernández Aceñero Tags: BRIEF REPORT Source Type: research
Molecular diagnostic techniques in cytopathology: From the bench to the patient's bedside
Diagnostic Cytopathology,Volume 46, Issue 7, Page 620-623, July 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Authors: CristinaD íaz del ArcoMD
,
Mª JesúsFernández AceñeroMD, PhD Source Type: research
Molecular diagnostic techniques in cytopathology: From the bench to the patient's bedside
Diagnostic Cytopathology, EarlyView. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
Cytological features of small cell carcinoma of the ovary ‐hypercalcemic type/malignant ovarian rhabdoid tumor in ascitic fluid
Diagnostic Cytopathology,Volume 46, Issue 4, Page 365-366, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
Utilization of direct smears of thyroid fine ‐needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms
Diagnostic Cytopathology,Volume 46, Issue 4, Page 320-325, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
---
Diagnostic Cytopathology, Ahead of Print. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
---
Diagnostic Cytopathology,Volume 46, Issue 4, Page 365-366, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
---
Diagnostic Cytopathology,Volume 46, Issue 4, Page 320-325, April 2018. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Source Type: research
Utilization of direct smears of thyroid fine ‐needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms
ConclusionThis study demonstrates that two molecular testing platforms performed equally well using our stained direct smears. Both molecular tests revealed a 100% negative predictive rate. RosettaGX showed a 75% positive predictive value in comparison to 60% for ThyGenX/ThyraMIR. (Source: Diagnostic Cytopathology)
Source: Diagnostic Cytopathology - February 15, 2018 Category: Pathology Authors: Kristen L. Partyka, Melissa L. Randolph, Karen A. Lawrence, Harvey Cramer, Howard H. Wu Tags: ORIGINAL ARTICLE Source Type: research
